“CVS Dismantling Healthcare Empire: Regulatory Tailwinds v. Cost Headwinds”
AI summary · CVS's split (not before 2028) is not proof its integrated strategy failed: retail pharmacy has gained share and returned to healthy growth, and the move responds to PBM transparency and Tennessee ownership rules. But the 12% drop reflects sum-of-parts math—retail peers at 7 to 8 times EBITDA versus insurers at 11.5 to 12.5—and added dual-listing costs; standalone valuation is key. Vertical integration likely continues unless Congress acts.
I mean, CVS spent years building this integrated healthcare giant , only to come along now as part of its strategic evaluation and say, "We're going to split into two publicly traded companies ."
Is this an admission that it did not succeed as they wanted, and that the administration did not achieve what was expected of it ?